Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Qazi

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
The West Virginia Medical Journal|April 1, 1994
Idiopathic long q-t syndrome: brief case report and discussionW E Noble, P Chaudhuri, M A Qazi
Journal of Postgraduate Medicine|March 26, 2013
Vismodegib: the first drug approved for advanced and metastatic basal cell carcinomaA K Dubey, S Dubey, S S Handu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 14, 2017
Intratumoral heterogeneity: pathways to treatment resistance and relapse in human glioblastomaM A Qazi, P Vora, C Venugopal, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
The West Virginia Medical Journal|April 1, 1994
Idiopathic long q-t syndrome: brief case report and discussionW E Noble, P Chaudhuri, M A Qazi
Journal of Postgraduate Medicine|March 26, 2013
Vismodegib: the first drug approved for advanced and metastatic basal cell carcinomaA K Dubey, S Dubey, S S Handu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 14, 2017
Intratumoral heterogeneity: pathways to treatment resistance and relapse in human glioblastomaM A Qazi, P Vora, C Venugopal, et al.
Pageof 1